• This is associated with symptoms of testosterone deficiency, not only of sexual functioning but also of bone density, muscle mass and metabolic risk factor for cardiovascular disease and diabetes
• The diagnosis is based both on clinical symptoms and on laboratory measurements, more so of free testosterone than of total testosterone.
• Treatment with testosterone is acceptably safe provided established guidelines are adhered to
NieschlagE., SwerdloffR., et al.Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol, 2005; 48(1):1–4.
KaufmanJ.M., VermeulenA.The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev, 2005; 26(6):833–876.
5.
HandelsmanD.J.Testicular dysfunction in systemic disease. Endocrinol Metab Clin North Am, 1994; 23(4):839–856.
6.
BhasinS., WoodhouseL., et al.Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab, 2005; 90(2):678–688.
7.
GoorenL.J.Androgen levels and sex functions in testosterone-treated hypogonadal men. Arch Sex Behav, 1987; 16(6):463–473.
8.
SchiaviR.C., RehmanJ.Sexuality and aging. Urol Clin North Am, 1995; 22(4):711–726.
9.
GrayP.B., SinghA.B., et al.Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. J Clin Endocrinol Metab, 2005; 90(7):3838–3846.
10.
AraujoA.B., O’DonnellA.B., et al.Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab, 2004; 89(12):5920–5926.
11.
LiuP.Y., PincusS.M., et al.Aging attenuates both the regularity and joint synchrony of LH and testosterone secretion in normal men: analyses via a model of graded GnRH receptor blockade. Am J Physiol Endocrinol Metab, 2006; 290(1):E34–E41.
12.
VermeulenA.Androgen replacement therapy in the aging male–a critical evaluation. J Clin Endocrinol Metab, 2001; 86(6):2380–2390.
13.
MatsumotoA.M.Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci, 2002; 57(2):M76–M99.
14.
MullerM., den TonkelaarI., et al.Endogenous sex hormones in men aged 40–80 years. Eur J Endocrinol, 2003; 149(6):583–589.
15.
VermeulenA., VerdonckL., et al.A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab, 1999; 84(10):3666–3672.
16.
SodergardR., BackstromT., et al.Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem, 1982; 16(6):801–810.
17.
BlackA.M., DayA.G., et al.The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial?. BJU Int, 2004; 94(7):1066–1070.
